Impact of fatigue in patients with chronic obstructive pulmonary disease: Results from an exploratory study

Therapeutic Advances in Respiratory Disease

Volumn 10, Issue 1, 2016, Pages 26-33

  Antoniu, Sabina Antonela ^a   Petrescu, Elena ^a   Stanescu, Raluca ^a   Anisie, Ecaterina ^a   Boiculese, Lucian ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

chronic obstructive pulmonary disease; fatigue; health status; health related quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL COPD QUESTIONNAIRE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY SCALE FOR FATIGUE; HEALTH STATUS; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; CASE CONTROL STUDY; HEALTH SURVEY; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84957596941     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465815617707     Document Type: Article

References (20)

1. Al-Shair K., Kolsum U., Dockry R., Morris J., Singh D., Vestbo J., (2011) Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 12: 3.
2. Al-Shair K., Müllerova H., Yorke J., Rennard S., Wouters E., Hanania N., et al. (2012) Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 10: 100.
3. Amann M., Regan M., Kobitary H., Eldridge M., Boutellier U., Pegelow D., et al. (2010) Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD. Am J Physiol Regul Integr Comp Physiol 299: R314-R324.
4. American Thoracic Society. (1995) Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152: 1107-1136.
5. Andersson M., Stridsman C., Ronmark E., Lindberg A., Emtner M., (2015) Physical activity and fatigue in chronic obstructive pulmonary disease-a population based study. Respir Med 109: 1048-1057.
6. Antoniu S., Ungureanu D., (2015) Measuring fatigue as a symptom in COPD: from descriptors and questionnaires to the importance of the problem. Chron Respir Dis 12: 179-188.
7. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117.
8. Boosman H., Visser-Meily J., Meijer J., Elsinga A., Post M., (2010) Evaluation of change in fatigue, self-efficacy and health-related quality of life, after a group educational intervention programme for persons with neuromuscular diseases or multiple sclerosis: a pilot study. Disabil Rehabil 33: 690-696.
9. Casaburi R., Mahler D., Jones P., Wanner A., San Pedro G., ZuWallack R., et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217-224.
10. Casale R., Farina D., Merletti R., Rainoldi A., (2004) Myoelectric manifestations of fatigue during exposure to hypobaric hypoxia for 12 days. Muscle Nerve 30: 618-625.
11. Cho H., Kivimäki M., Bower J., Irwin M., (2013) Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study. Psychol Med 43: 1773-1783.
12. Druce K., Jones G., Macfarlane G., Basu N., (2015) Determining pathways to improvements in fatigue in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Rheumatol 67: 2303-2310.
13. Fernández O., Baumstarck-Barrau K., Simeoni M., Auquier P., (2011) Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires. Mult Scler J 17: 1238-1249.
14. Grant S., Aitchison T., Henderson E., Christie J., Zare S., McMurray J., et al. (1999) A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest 116: 1208-1217.
15. Janssen D., Müllerova H., Agusti A., Yates J., Tal-Singer R., Rennard S., et al. (2014) Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med 108: 1647-1654.
16. Stridsman C., Müllerova H., Skar L., Lindberg A., (2013) Fatigue in COPD and the impact of respiratory symptoms and heart disease-a population-based study. COPD 10: 125-132.
17. Stridsman C., Skar L., Hedman L., Rönmark E., Lindberg A., (2015) Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD 12: 199-206.
18. van der Molen T., Willemse B., Schokker S., ten Hacken N., Postma D., Juniper E., (2003) Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 1: 13.
19. Ware J. Jr, Sherbourne C., (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
20. Zattara-Hartmann M., Badier M., Guillot C., Tomei C., Jammes Y., (1995) Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 18: 495-502.